Neostigmine Methylsulfate
NDC 70069-806, Neostigmine Methylsulfate, injection, from Somerset Therapeutics, LLC.
- Product NDC
- 70069-806
- Status
- Listed
- Labeler
- Somerset Therapeutics, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213074
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70069-806 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE1 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70069-806-10 | 70069080610 | 10 VIAL, MULTI-DOSE in 1 CARTON (70069-806-10) / 10 mL in 1 VIAL, MULTI-DOSE (70069-806-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ea767851-b0ab-4a4c-a4b2-680ff4086636
Use it
Look up 70069-806 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70069-806 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70069-806. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.